Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993 Kunihiko Inoue, MDa, Masami.

Slides:

Advertisements

Similar presentations

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Advertisements

PUBLISH ONLY Journal of Thoracic Oncology

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis? Noriyoshi.

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

The effect of preoperative methylprednisolone on pulmonary function and pain after lung operations Dennis Bigler, MDa, Torsten Jonsson, MDa, Johnny Olsen,

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Mechanical circulatory support in children with cardiac disease

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.

Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience Tsuguo Naruke,

A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,

Survival after resection of synchronous non–small cell lung cancer

Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection* T. Sakuma, MD, H. Kubo, MD, T. Tanita, MD, K.

Tumors of the esophagogastric junction

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy Morihito Okada, MD, Hiroyuki Yamagishi,

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis

Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD

Successful localization and treatment for ectopic adrenocorticotrophic hormone secretion in a rare case of possible Tx N2 M0 carcinoid tumor with Cushing.

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Superior vena cava syndrome caused by pulmonary artery sarcoma

Rodney J. Landreneau, MDa, David J. Sugarbaker, MDb, Michael J

Prognostic factors in clinical stage I non–small cell lung cancer

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,

Preoperative evidence of circulating tumor cells by means of reverse transcriptase- polymerase chain reaction for carcinoembryonic antigen messenger RNA.

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer J. Buhr,

Lorenzo Spaggiari, MD, PhD, Ugo Pastorino, MD

The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer Yukito Ichinose, MDa, Tokujiro.

PUBLISH ONLY Journal of Thoracic Oncology

Michael Bousamra, MDa, George B. Haasler, MDa, Randolph J

Subclavian artery involvement by apical chest tumors: A specific indication for the transmanubrial approach Lorenzo Spaggiari, MD, PhD, Ugo Pastorino,

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Support Your Specialty

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification Jacek Jassem, MDa, Jan.

Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl Lewis X, and sialyl Lewis a in lung cancer Jun-ichi Ogawa, MD,

Subxiphoid pericardial drainage for pericardial tamponade

Time trends and survival after operations for primary lung cancer from 1976 through 1990 Hiromi Wada, MD, Fumihiro Tanaka, MD, Kazuhiro Yanagihara, MD,

Yuji Tachimori, MD, Hoichi Kato, MD, Hiroshi Watanabe, MD

Frederick L. Grover, MDa, b, David J

Immune-Modulating Vaccines in Non-small Cell Lung Cancer

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Lewis Y antigen expression and postoperative survival in non–small cell lung cancer Fumihiro Tanaka, MD, Ryo Miyahara, MD, Yohsuke Ohtake, MD, Kazuhiro.

Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non- small Cell Lung Cancer Takeshi Hanagiri, MD, PhD, Kenji Sugio, MD,

Lymph Node Metastasis In Small Peripheral Adenocarcinoma Of The Lung

Carcinoma of the esophagus: Prognostic significance of histologic type

Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non–small cell lung cancer Dominique H. Grunenwald, MDa, Fabrice André, MDb,

Problems related to TNM staging: Patients with stage III non–small cell lung cancer Kotaro Kameyama, MD, Cheng-long Huang, MD, Dage Liu, MD, Taku Okamoto,

Superior sulcus lung tumors: Impact of local control on survival

Discussion The Journal of Thoracic and Cardiovascular Surgery

Second operation for upper mediastinal lymphadenopathy after complete resection for cancer of the left lung Masami Sato, MDa, b, Teruaki Koike, MDa,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Experience with one and a half ventricle repair

Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams V.Mohan Reddy, MDa, Doff B. McElhinney, MDa,

Primary repair is superior to initial palliation in children with atrioventricular septal defect and tetralogy of fallot Hani K. Najm, MDa, Glen S. Van.

Thomas J. Kirby, MDa (by invitation), Michael J

Aritoshi Hattori, MD, Kenji Suzuki, MD

Prognostic factors and long-term results after thymoma resection: A series of 307 patients Jean-François Regnard, MDa, Pierre Magdeleinat, MDa, Christian.

Salvage surgery for advanced non–small cell lung cancer after response to gefitinib Tomoyuki Hishida, MD, Kanji Nagai, MD, Tetsuya Mitsudomi, MD, Kohei.

Minimally invasive direct coronary artery bypass, percutaneous transluminal coronary angioplasty, and stent placement for left main stenosis William.

Who should decide margin length in pulmonary excision of lung cancer?

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

The tp53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non–small cell lung.

Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.

Nael Martini, MDa, Valerie W. Rusch, MDa, Manjit S. Bains, MDa, Mark G

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Prognostic Significance of Tumor Size in Patients with Stage III Non–Small-Cell Lung Cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey.

Presentation transcript:

Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993 Kunihiko Inoue, MDa, Masami Sato, MDa, Shigefumi Fujimura, MDa, Akira Sakurada, MDa, Satomi Takahashi, MDb, Katsuo Usuda, MDb, Takashi Kondo, MDa, Tatsuo Tanita, MDa, Masashi Handa, MDb, Yasuki Saito, MDc, Motoyasu Sagawa, MDa The Journal of Thoracic and Cardiovascular Surgery Volume 116, Issue 3, Pages 407-411 (September 1998) DOI: 10.1016/S0022-5223(98)70006-6 Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 1 The postoperative survival curves of patients with T1 N0 M0, T2 N0 M0, T1 N1 M0, and T2 N1 M0 diseases show that there are significant differences between the prognoses of patients with T1 N0 M0 and T2 N0 M0 diseases (P = .001) and between those of patients with T1 N1 M0 and T2 N1 M0 diseases (P = .02). The Journal of Thoracic and Cardiovascular Surgery 1998 116, 407-411DOI: (10.1016/S0022-5223(98)70006-6) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 2 The postoperative survival curves show that there are no significant differences in the survivals among of patients with T2 N1 M0, T3 N0 M0, and T3 N1 M0 diseases. The Journal of Thoracic and Cardiovascular Surgery 1998 116, 407-411DOI: (10.1016/S0022-5223(98)70006-6) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 3 The postoperative survival curves of patients with T3 N0-1 M0 diseases show that, according to the invaded organ, patients with resected T3 tumors invading the diaphragm have a poor prognosis. The Journal of Thoracic and Cardiovascular Surgery 1998 116, 407-411DOI: (10.1016/S0022-5223(98)70006-6) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 4 The postoperative survival curves of patients with T3 N2 M0 and stage IIIB diseases show that there is no significant difference between the prognoses. The Journal of Thoracic and Cardiovascular Surgery 1998 116, 407-411DOI: (10.1016/S0022-5223(98)70006-6) Copyright © 1998 Mosby, Inc. Terms and Conditions